Concepedia

Fady I. Malik

FI

Statistics

Publications

77

Citations

6.1K

H-Index

36

Active since

1990

Affiliations

Cytokinetics (United States)(Current)

University of California, San Francisco

Brigham and Women's Hospital

University of Glasgow

Harvard University

Fady I. Malik is an author at Cytokinetics (United States) specializing in medicine, cardiology, and heart failure.

ORCID

Publications per year

1990–2025

77

Publications

77

Cardiac Myosin Activation with Omecamtiv Mecarbil in Systolic Heart Failure

John R. Teerlink, Rafael Díaz, G. Michael Felker et al. · New England Journal of Medicine · 2020 · 644 citations · Full text

, , +15

Cardiac Myosin Activation: A Potential Therapeutic Approach for Systolic Heart Failure

Fady I. Malik, James J. Hartman, Kathleen A. Elias et al. · Science · 2011 · 596 citations

, , +17

The effects of the cardiac myosin activator, omecamtiv mecarbil, on cardiac function in systolic heart failure: a double-blind, placebo-controlled, crossover, dose-ranging phase 2 trial

John G.F. Cleland, John R. Teerlink, Roxy Senior et al. · The Lancet · 2011 · 331 citations

, , +14

Chronic Oral Study of Myosin Activation to Increase Contractility in Heart Failure (COSMIC-HF): a phase 2, pharmacokinetic, randomised, placebo-controlled trial

John R. Teerlink, G. Michael Felker, John J.V. McMurray et al. · The Lancet · 2016 · 293 citations · Full text

, , +10

Aficamten for Symptomatic Obstructive Hypertrophic Cardiomyopathy

Martin S. Maron, Ahmad Masri, Michael E. Nassif et al. · New England Journal of Medicine · 2024 · 282 citations · Full text

, , +14

1–5 of 77